---
id: 6076
title: "ASIT Biotech: Best Biopharmaceutical Corporate Governance Belgium 2018"
award_year: 2018
published: 2018-10-08 14:35:35
published_gmt: 2018-10-08 13:35:35
author: "CFI.co Editorial"
url: "https://cfi.co/awards/best-practice/2018/asit-biotech-best-biopharmaceutical-corporate-governance-belgium-2018/"
categories: ["Best Practice", "Corporate Governance"]
content_class: award_rationale
independence_status: independent_editorial
sponsor_disclosure: none
editorial_lens: constructive_positive_lens
historical_status: current_at_publication
correction_status: none
archive_policy: no_delete
provenance_layer: github_versioned
wayback_status: archived
wayback_first_snapshot: 20260525055020
wayback_snapshot_url: "http://web.archive.org/web/20260525055020/https://cfi.co/awards/best-practice/2018/asit-biotech-best-biopharmaceutical-corporate-governance-belgium-2018/"
license: CFI-OAAL-1.0
content_sha256: 89f852655710a4bd96722664ee84f342868f9f5e4eda62529f92f4237ad90806
canonical: 6076-asit-biotech-best-biopharmaceutical-corporate-governance-belgium-2018.json
---

# ASIT Biotech: Best Biopharmaceutical Corporate Governance Belgium 2018

> Verbatim archived copy. Canonical machine record: `6076-asit-biotech-best-biopharmaceutical-corporate-governance-belgium-2018.json`.

<img class="aligncenter size-full wp-image-6077" src="https://cfi.co/awards/wp-content/uploads/2018/10/ASIT.jpg" alt="" width="399" height="103" />
<p style="text-align: justify;"><strong>In the fast-moving Biopharma world, corporate governance can sometimes be low on the priority list and is sometime viewed as little more than a tick box exercise.</strong> As a result, many companies have failed to raise the capital they need to succeed. The CFI.co judging panel were seeking an example of a Biopharma that had used the implementation of high governance standards as an enabler for success. ASIT Biotech have given their corporate governance the same level of attention they give to their science. ASIT have been constantly evolving and refining their governance and have ensured the correct business/academic and executive/non-executive balance that in combination with strong product potential has helped deliver several rounds of funding. This year saw the board call in independent evaluation that will help them further strengthen their governance as they look to bring their breakthrough immunotherapy products to market in the near future. The CFI.co judging panel reflected on ASIT’s constant efforts to ensure the correct level of governance to deliver their innovative technology to market and are pleased to announce  ASIT Biotech as winner of the award Best Biopharmaceutical Corporate Governance Belgium 2018.</p>